Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 521

1.

Phenotyping multiple subsets in Sjögren's syndrome: a salivary proteomic SWATH-MS approach towards precision medicine.

Cecchettini A, Finamore F, Ucciferri N, Donati V, Mattii L, Polizzi E, Ferro F, Sernissi F, Mosca M, Bombardieri S, Rocchiccioli S, Baldini C.

Clin Proteomics. 2019 Jun 20;16:26. doi: 10.1186/s12014-019-9245-1. eCollection 2019.

2.

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines.

Antunes M, Scirè CA, Talarico R, Alexander T, Avcin T, Belocchi C, Doria A, Franceschini F, Galetti I, Govoni M, Hachulla E, Launay D, Lepri G, Macieira C, Matucci-Cerinic M, Montecucco CM, Moraes-Fontes MF, Mouthon L, Paolino S, Ramoni V, Tani C, Tas SW, Tincani A, Van Vollenhoven R, Zen M, Fonseca J, Bombardieri S, Fonseca JE, Schneider M, Smith V, Cutolo M, Mosca M, Beretta L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000786. doi: 10.1136/rmdopen-2018-000786. eCollection 2018. Review.

3.

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Meyer A, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Barsotti S, Beretta L, Blagojevic J, Burmester G, Cavazzana I, Cherrin P, Damian L, Doria A, Fonseca JE, Furini F, Galetti I, Houssiau F, Krieg T, Maddalena L, Launay D, Campanilho-Marques R, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Moraes-Fontes MF, Mouthon L, Neri R, Paolino S, Piette Y, Rednic S, Tamirou F, Tincani A, Toplak N, Bombardieri S, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Cavagna L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review. Erratum in: RMD Open. 2019 Apr 15;5(1):e000784corr1.

4.

MicroRNA-mediated Regulation of Mucin-type O-glycosylation Pathway: A Putative Mechanism of Salivary Gland Dysfunction in Sjögren Syndrome.

Gallo A, Vella S, Tuzzolino F, Cuscino N, Cecchettini A, Ferro F, Mosca M, Alevizos I, Bombardieri S, Conaldi PG, Baldini C.

J Rheumatol. 2019 Mar 1. pii: jrheum.180549. doi: 10.3899/jrheum.180549. [Epub ahead of print]

PMID:
30824638
5.

IgG4-related diseases: state of the art on clinical practice guidelines.

Iaccarino L, Talarico R, Scirè CA, Amoura Z, Burmester G, Doria A, Faiz K, Frank C, Hachulla E, Hie M, Launay D, Montecucco C, Monti S, Mouthon L, Tincani A, Toniati P, Van Hagen PM, Van Vollenhoven RF, Bombardieri S, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Alexander T.

RMD Open. 2019 Jan 19;4(Suppl 1):e000787. doi: 10.1136/rmdopen-2018-000787. eCollection 2018. Review.

6.

Behçet's syndrome and psychiatric involvement: is it a primary or secondary feature of the disease?

Talarico R, Palagini L, Elefante E, Ferro F, Tani C, Gemignani A, Bombardieri S, Mosca M.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):125-128. Epub 2018 Dec 13.

7.

Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.

RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. Review.

8.

Ehlers-Danlos syndromes: state of the art on clinical practice guidelines.

Sulli A, Talarico R, Scirè CA, Avcin T, Castori M, Ferraris A, Frank C, Grunert J, Paolino S, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Malfait F.

RMD Open. 2018 Oct 18;4(Suppl 1):e000790. doi: 10.1136/rmdopen-2018-000790. eCollection 2018.

9.

Sjögren's syndrome: state of the art on clinical practice guidelines.

Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, Gottenberg JE, Gruner H, Hachulla E, Mouthon L, Orlandi M, Pamfil C, Pineton de Chambrun M, Taglietti M, Toplak N, van Daele P, van Laar JM, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Mariette X.

RMD Open. 2018 Oct 18;4(Suppl 1):e000789. doi: 10.1136/rmdopen-2018-000789. eCollection 2018.

10.

Relapsing polychondritis: state of the art on clinical practice guidelines.

Rednic S, Damian L, Talarico R, Scirè CA, Tobias A, Costedoat-Chalumeau N, Launay D, Mathian A, Mattews L, Ponte C, Toniati P, Bombardieri S, Frank C, Schneider M, Smith V, Cutolo M, Mosca M, Arnaud L.

RMD Open. 2018 Oct 18;4(Suppl 1):e000788. doi: 10.1136/rmdopen-2018-000788. eCollection 2018.

11.

Antiphospholipid syndrome: state of the art on clinical practice guidelines.

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.

RMD Open. 2018 Oct 18;4(Suppl 1):e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

12.

Mixed connective tissue disease: state of the art on clinical practice guidelines.

Chaigne B, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Beretta L, Doria A, Guffroy A, Guimarães V, Hachulla É, Krieg T, Launay D, Lepri G, Moinzadeh P, Müller-Ladner U, Rednic S, Rodrigues A, Tas SW, van Vollenhoven RF, Vieira A, Bombardieri S, Fonseca JE, Galetti I, Schneider M, Smith V, Cutolo M, Mosca M, Fischer-Betz R.

RMD Open. 2018 Oct 18;4(Suppl 1):e000783. doi: 10.1136/rmdopen-2018-000783. eCollection 2018.

13.

Systemic sclerosis: state of the art on clinical practice guidelines.

Smith V, Scirè CA, Talarico R, Airo P, Alexander T, Allanore Y, Bruni C, Codullo V, Dalm V, De Vries-Bouwstra J, Della Rossa A, Distler O, Galetti I, Launay D, Lepri G, Mathian A, Mouthon L, Ruaro B, Sulli A, Tincani A, Vandecasteele E, Vanhaecke A, Vanthuyne M, Van den Hoogen F, Van Vollenhoven R, Voskuyl AE, Zanatta E, Bombardieri S, Burmester G, Eurico FJ, Frank C, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, van Laar JM, Vieira A, Cutolo M, Mosca M, Matucci-Cerinic M.

RMD Open. 2018 Oct 18;4(Suppl 1):e000782. doi: 10.1136/rmdopen-2018-000782. eCollection 2018.

14.

Advances in salivary gland ultrasonography in primary Sjögren's syndrome.

Luciano N, Ferro F, Bombardieri S, Baldini C.

Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):159-164. Epub 2018 Oct 1. Review.

15.

Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.

Baldini C, Ferro F, Luciano N, Bombardieri S, Grossi E.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):137-144. Epub 2018 Aug 14.

16.

Biomarkers for Sjögren's syndrome.

Baldini C, Ferro F, Elefante E, Bombardieri S.

Biomark Med. 2018 Mar;12(3):275-286. doi: 10.2217/bmm-2017-0297. Epub 2018 Feb 20. Review.

PMID:
29460647
17.

Classification criteria in Sjögren's syndrome.

Baldini C, Ferro F, Bombardieri S.

Ann Transl Med. 2017 Aug;5(15):313. doi: 10.21037/atm.2017.05.07. No abstract available.

18.

What could we learn from the sub-analysis of a single nation cohort in a worldwide study? Lessons from the results observed in the Italian cohort of the GO-MORE trial.

Giacomelli R, Ruscitti P, Bombardieri S, Cuomo G, De Vita S, Galeazzi M, Mecchia M; Italian GO-MORE Investigators.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):623-629. Epub 2017 Jun 6.

PMID:
28598774
19.

Updates on Sjögren's syndrome: from proteomics to protein biomarkers.

Baldini C, Cecchettini A, Gallo A, Bombardieri S.

Expert Rev Proteomics. 2017 Jun;14(6):491-498. doi: 10.1080/14789450.2017.1333904. Epub 2017 May 26. Review.

PMID:
28532233
20.

Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study.

Caporali R, Idolazzi L, Bombardieri S, Ferraccioli G, Gerli R, Govoni M, Matucci Cerinic M, Pomponio G, Salaffi F, Tirri R, Benaglio F, Bianchino L, Sarzi-Puttini P; TRUST study investigators.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):919-928. Epub 2017 May 8.

PMID:
28516890
21.

Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue.

Quartuccio L, Baldini C, Priori R, Bartoloni E, Carubbi F, Alunno A, Gandolfo S, Colafrancesco S, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S; GRISS Group.

J Rheumatol. 2017 Aug;44(8):1179-1183. doi: 10.3899/jrheum.161465. Epub 2017 May 15.

PMID:
28507188
22.

Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjögren's syndrome.

Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Alunno A, Gandolfo S, Gattamelata A, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S; GRISS Group (Gruppo di Ricerca Italiano sulla Sindrome di Sjögren).

Clin Exp Rheumatol. 2017 May-Jun;35(3):546-547. Epub 2017 Feb 10. No abstract available.

PMID:
28229815
23.

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome.

Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P, Bombardieri S, Ng WF, Tzioufas AG, Vitali C, Shirlaw P, Haacke E, Costa S, Bootsma H, Devauchelle-Pensec V, Radstake TR, Mariette X, Richards A, Stack R, Bowman SJ, Barone F; Sjögren's histopathology workshop group (appendix) from ESSENTIAL (EULAR Sjögren's syndrome study group).

Ann Rheum Dis. 2017 Jul;76(7):1161-1168. doi: 10.1136/annrheumdis-2016-210448. Epub 2016 Dec 13.

24.

Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center.

Barsotti S, Zampa V, Talarico R, Minichilli F, Ortori S, Iacopetti V, D'ascanio A, Tavoni AG, Bombardieri S, Mosca M, Neri R.

Muscle Nerve. 2016 Oct;54(4):666-72. doi: 10.1002/mus.25099. Epub 2016 Jun 9.

PMID:
27279002
25.

Salivary Gland Ultrasonography in Sjögren's Syndrome: Clinical Usefulness and Future Perspectives.

Baldini C, Luciano N, Mosca M, Bombardieri S.

Isr Med Assoc J. 2016 Mar-Apr;18(3-4):193-6. Review.

26.

Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.

Sfriso P, Priori R, Valesini G, Rossi S, Montecucco CM, D'Ascanio A, Carli L, Bombardieri S, LaSelva G, Iannone F, Lapadula G, Alivernini S, Ferraccioli G, Colaci M, Ferri C, Iacono D, Valentini G, Costa L, Scarpa R, LoMonaco A, Bagnari V, Govoni M, Piazza I, Adami S, Ciccia F, Triolo G, Alessandri E, Cutolo M, Cantarini L, Galeazzi M, Ruscitti P, Giacomelli R, Caso F, Galozzi P, Punzi L.

Clin Rheumatol. 2016 Jul;35(7):1683-9. doi: 10.1007/s10067-016-3308-8. Epub 2016 May 20.

PMID:
27207567
27.

Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.

Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntmann V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, van Rossum A, Rademakers F, Pohost G, Lima JA.

Int J Cardiol. 2016 Aug 15;217:135-48. doi: 10.1016/j.ijcard.2016.04.158. Epub 2016 Apr 27. Review.

PMID:
27179903
28.

Asthma Control and Airway Inflammation in Patients with Eosinophilic Granulomatosis with Polyangiitis.

Latorre M, Baldini C, Seccia V, Pepe P, Novelli F, Celi A, Bacci E, Cianchetti S, Dente FL, Bombardieri S, Paggiaro P.

J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):512-9. doi: 10.1016/j.jaip.2015.12.014. Epub 2016 Feb 13.

PMID:
26883543
29.

The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients With Sjögren's Syndrome: Comment on the Article by Nocturne et al.

Quartuccio L, Baldini C, Bombardieri S, Priori R, Valesini G, Bartoloni E, Alunno A, Gerli R, Carubbi F, Giacomelli R, De Vita S.

Arthritis Rheumatol. 2016 May;68(5):1318-9. doi: 10.1002/art.39585. No abstract available.

30.

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.

Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Bombardieri S, de Vita S, Mandl T, Ng WF, Kruize AA, Tzioufas A, Vitali C, Buyon J, Izmirly P, Fox R, Ramos-Casals M; Eular Sjögren Syndrome Task Force.

Expert Rev Clin Immunol. 2016;12(2):137-56. doi: 10.1586/1744666X.2016.1109449. Epub 2015 Dec 22. Review. Erratum in: Expert Rev Clin Immunol. 2017 May;13(5):507.

PMID:
26691952
31.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C.

RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. Review.

32.

Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.

Virdis A, Tani C, Duranti E, Vagnani S, Carli L, Kühl AA, Solini A, Baldini C, Talarico R, Bombardieri S, Taddei S, Mosca M.

Arthritis Res Ther. 2015 Oct 6;17:277. doi: 10.1186/s13075-015-0790-3.

33.

Azathioprine-induced accelerated cutaneous and pulmonary nodulosis in a patient with rheumatoid arthritis.

Kellet CV, Navarrete RA, Bombardieri SG, Manriquez J.

An Bras Dermatol. 2015 May-Jun;90(3 Suppl 1):162-4. doi: 10.1590/abd1806-4841.20153750.

34.

Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.

Quartuccio L, Zuliani F, Corazza L, Scaini P, Zani R, Lenzi M, Tavoni A, Sebastiani M, Baldovino S, Urraro T, Saccardo F, Sbreglia C, Mazzaro C, Pioltelli P, Fraticelli P, Filippini D, Gabrielli A, Perrella O, Scarpato S, Roccatello D, Zignego AL, Ferri C, Bombardieri S, Pietrogrande M, Monti G, Galli M, De Vita S.

J Autoimmun. 2015 Sep;63:88-93. doi: 10.1016/j.jaut.2015.07.012. Epub 2015 Aug 5.

35.

Impact of gender, work, and clinical presentation on diagnostic delay in Italian patients with primary ankylosing spondylitis.

Bandinelli F, Salvadorini G, Delle Sedie A, Riente L, Bombardieri S, Matucci-Cerinic M.

Clin Rheumatol. 2016 Feb;35(2):473-8. doi: 10.1007/s10067-015-3005-z. Epub 2015 Aug 4.

PMID:
26238665
36.

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.

Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Theander E, Bombardieri S, De Vita S, Mandl T, Ng WF, Kruize A, Tzioufas A, Vitali C; EULAR Sjögren Syndrome Task Force.

Rheumatology (Oxford). 2015 Dec;54(12):2230-8. doi: 10.1093/rheumatology/kev200. Epub 2015 Jul 31. Erratum in: Rheumatology (Oxford). 2017 Jul 1;56(7):1245.

37.

Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjögren's syndrome from undifferentiated connective tissue diseases.

Luciano N, Baldini C, Tarantini G, Ferro F, Sernissi F, Varanini V, Donati V, Martini D, Mosca M, Caramella D, Bombardieri S.

Rheumatology (Oxford). 2015 Dec;54(12):2198-204. doi: 10.1093/rheumatology/kev253. Epub 2015 Jul 23.

PMID:
26206346
38.

Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.

Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Corazza L, Alunno A, Colafrancesco S, Luciano N, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S.

Autoimmun Rev. 2015 Nov;14(11):1019-22. doi: 10.1016/j.autrev.2015.07.002. Epub 2015 Jul 8. Review.

PMID:
26162302
39.

Myositis in primary Sjögren's syndrome: data from a multicentre cohort.

Colafrancesco S, Priori R, Gattamelata A, Picarelli G, Minniti A, Brancatisano F, D'Amati G, Giordano C, Cerbelli B, Maset M, Quartuccio L, Bartoloni E, Carubbi F, Cipriani P, Baldini C, Luciano N, De Vita S, Gerli R, Giacomelli R, Bombardieri S, Valesini G.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):457-64. Epub 2015 Jun 19.

PMID:
26088683
40.

Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome.

Baldini C, Luciano N, Tarantini G, Pascale R, Sernissi F, Mosca M, Caramella D, Bombardieri S.

Arthritis Res Ther. 2015 May 28;17:146. doi: 10.1186/s13075-015-0657-7.

41.

Development of de novo major involvement during follow-up in Behçet's syndrome.

Talarico R, Cantarini L, d'Ascanio A, Figus M, Favati B, Baldini C, Tani C, Neri R, Bombardieri S, Mosca M.

Clin Rheumatol. 2016 Jan;35(1):247-50. doi: 10.1007/s10067-015-2906-1. Epub 2015 Mar 8.

PMID:
25750177
42.

Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome.

Talarico R, Palagini L, d'Ascanio A, Elefante E, Ferrari C, Stagnaro C, Tani C, Gemignani A, Mauri M, Bombardieri S, Mosca M.

CNS Drugs. 2015 Mar;29(3):189-96. doi: 10.1007/s40263-015-0228-0. Review.

PMID:
25643894
43.

Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study.

Bartoloni E, Baldini C, Schillaci G, Quartuccio L, Priori R, Carubbi F, Bini V, Alunno A, Bombardieri S, De Vita S, Valesini G, Giacomelli R, Gerli R.

J Intern Med. 2015 Aug;278(2):185-92. doi: 10.1111/joim.12346. Epub 2015 Feb 3.

44.

In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience.

Gabbriellini G, Baldini C, Varanini V, Notarstefano C, Pepe P, Fanucci F, Ferro F, Luciano N, Mosca M, Nardi M, Bombardieri S.

Mod Rheumatol. 2015 Jul;25(4):585-9. doi: 10.3109/14397595.2014.979523. Epub 2014 Dec 15.

PMID:
25496408
45.

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2016 Feb;75(2):382-9. doi: 10.1136/annrheumdis-2014-206008. Epub 2014 Dec 5.

PMID:
25480887
46.

A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate.

Galeazzi M, Bazzichi L, Sebastiani GD, Neri D, Garcia E, Ravenni N, Giovannoni L, Wilton J, Bardelli M, Baldi C, Selvi E, Iuliano A, Minisola G, Caporali R, Prisco E, Bombardieri S.

Isr Med Assoc J. 2014 Oct;16(10):666. No abstract available.

47.

Erratum to: MRI pattern of arthritis in systemic lupus erythematosus: a comparative study with rheumatoid arthritis and healthy subjects.

Tani C, D'Aniello D, Possemato N, Delle Sedie A, Caramella D, Bombardieri S, Mosca M.

Skeletal Radiol. 2015 Feb;44(2):267. doi: 10.1007/s00256-014-2054-8. No abstract available.

PMID:
25391417
48.

Neuropsychiatric questionnaires in systemic lupus erythematosus.

Tani C, Palagini L, Moraes-Fontes MF, Carli L, Mauri M, Bombardieri S, Mosca M.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-59-64. Epub 2014 Oct 30. Review.

PMID:
25365091
50.

Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus.

Bortoluzzi A, Scirè CA, Bombardieri S, Caniatti L, Conti F, De Vita S, Doria A, Ferraccioli G, Gremese E, Mansutti E, Mathieu A, Mosca M, Padovan M, Piga M, Tincani A, Tola MR, Tomietto P, Valesini G, Zen M, Govoni M; Study Group on Neuropsychiatric Systemic Lupus Erythematosus of the Italian Society of Rheumatology.

Rheumatology (Oxford). 2015 May;54(5):891-8. doi: 10.1093/rheumatology/keu384. Epub 2014 Oct 21. Review.

PMID:
25339643

Supplemental Content

Loading ...
Support Center